Release Date: 20/05/21 15:35 Summary: Annual Report to Shareholders Price Sensitive: No Download Document 3.96MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%